Your browser doesn't support javascript.
loading
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.
Ligorio, Francesca; Di Cosimo, Serena; Verderio, Paolo; Ciniselli, Chiara Maura; Pizzamiglio, Sara; Castagnoli, Lorenzo; Dugo, Matteo; Galbardi, Barbara; Salgado, Roberto; Loi, Sherene; Michiels, Stefan; Triulzi, Tiziana; Tagliabue, Elda; El-Abed, Sarra; Izquierdo, Miguel; de Azambuja, Evandro; Nuciforo, Paolo; Huober, Jens; Moscetti, Luca; Janni, Wolfgang; Coccia-Portugal, Maria Antonia; Corsetto, Paola Antonia; Belfiore, Antonino; Lorenzini, Daniele; Daidone, Maria Grazia; Vingiani, Andrea; Gianni, Luca; Pupa, Serenella Maria; Bianchini, Giampaolo; Pruneri, Giancarlo; Vernieri, Claudio.
Afiliação
  • Ligorio F; Metabolic Reprogramming in Solid Tumors Unit, IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.
  • Di Cosimo S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Verderio P; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pizzamiglio S; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Castagnoli L; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Dugo M; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Galbardi B; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.
  • Salgado R; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.
  • Loi S; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
  • Michiels S; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Triulzi T; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Tagliabue E; Department of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • El-Abed S; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Izquierdo M; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • de Azambuja E; Breast International Group (BIG), Brussels, Belgium.
  • Nuciforo P; Novartis Pharma AG, Basel, Switzerland.
  • Huober J; Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium.
  • Moscetti L; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Janni W; Breast Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Coccia-Portugal MA; Department of Oncology-Hematology, University Hospital of Modena, Modena, Italy.
  • Corsetto PA; Gruppo Oncologico Italiano per la Ricerca Clinica, Parma, Italy.
  • Belfiore A; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
  • Lorenzini D; Clinical Trial Department, Eastleigh Breast Care Center, Pretoria, South Africa.
  • Daidone MG; Department of Pharmacology and Biomolecular Science, University of Milan, Milan, Italy.
  • Vingiani A; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gianni L; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pupa SM; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bianchini G; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pruneri G; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy.
  • Vernieri C; Fondazione Michelangelo, Milan, Italy.
J Natl Cancer Inst ; 114(12): 1720-1727, 2022 12 08.
Article em En | MEDLINE | ID: mdl-35789270
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article